EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C31H35F3N6O2 |
| Net Charge | 0 |
| Average Mass | 580.655 |
| Monoisotopic Mass | 580.27736 |
| SMILES | CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(NCc4cnc5nccc5c4OC)c3)cc2C(F)(F)F)CC1 |
| InChI | InChI=1S/C31H35F3N6O2/c1-4-39-11-13-40(14-12-39)19-22-7-6-21(15-26(22)31(32,33)34)30(41)38-24-8-5-20(2)27(16-24)36-17-23-18-37-29-25(9-10-35-29)28(23)42-3/h5-10,15-16,18,36H,4,11-14,17,19H2,1-3H3,(H,35,37)(H,38,41) |
| InChIKey | PBHDCPWPSOSGGD-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Role: | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that interferes with the action of receptor protein-tyrosine kinase (EC 2.7.10.1). |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| DDR1-IN-2 (CHEBI:191410) has role EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor (CHEBI:62434) |
| DDR1-IN-2 (CHEBI:191410) is a (trifluoromethyl)benzenes (CHEBI:83565) |
| DDR1-IN-2 (CHEBI:191410) is a N-alkylpiperazine (CHEBI:46845) |
| DDR1-IN-2 (CHEBI:191410) is a aromatic ether (CHEBI:35618) |
| DDR1-IN-2 (CHEBI:191410) is a benzamides (CHEBI:22702) |
| DDR1-IN-2 (CHEBI:191410) is a pyrrolopyridine (CHEBI:46771) |
| DDR1-IN-2 (CHEBI:191410) is a secondary carboxamide (CHEBI:140325) |
| IUPAC Name |
|---|
| 4-[(4-ethylpiperazin-1-yl)methyl]-N-(3-{[(4-methoxy-1H-pyrrolo[2,3-b]pyridin-5-yl)methyl]amino}-4-methylphenyl)-3-(trifluoromethyl)benzamide |
| Synonym | Source |
|---|---|
| 4-[(4-ethylpiperazin-1-yl)methyl]-N-[3-[(4-methoxy-1H-pyrrolo[2,3-b]pyridin-5-yl)methylamino]-4-methylphenyl]-3-(trifluoromethyl)benzamide | IUPAC |
| Manual Xrefs | Databases |
|---|---|
| 34955219 | ChemSpider |
| Registry Numbers | Sources |
|---|---|
| CAS:1315329-35-1 | ChEBI |
| Citations |
|---|